Tumor cells in colorectal cancer exploit an important signaling pathway that normally controls embryo development.

dual PARP and WNT pathway inhibitor—today announced the Company’s CEO, Thomas Jensen, will deliver a company overview focused on stenoparib and the Company’s DRP® companion diagnostic ...

Identifying proteomic signatures of insulin resistance in fasting muscle offers insights for personalized type 2 diabetes ...

A research team at the University of Würzburg has gained new insights into the development of kidney tumors in young children. These enable a better risk assessment and could form the basis for ...

Surrozen, Inc. ("Surrozen" or the "Company") (Nasdaq: SRZN), a biotechnology company pioneering targeted therapeutics that selectively modulate ...

An anthelminthic drug commonly used for pinworm infections could be repurposed to treat a deadly form of skin cancer, according to early study results.Researchers found pyrvinium pamoate significantly ...

SRIHER spine surgery team wins Best International Research Award for groundbreaking research on Wnt signaling pathway in spinal cord injuries.

Newly granted patent is part of the expanding intellectual property portfolio directed to: -generating novel and selective Wnt surrogate molecules with potentially broad therapeutic utility and ...

Kidney fibrosis, a common endpoint of chronic kidney disease (CKD), is strongly linked to aging, with cellular senescence ...

KRAS mutations are among the most common genetic alterations in cancer and are considered particularly difficult to treat.

MicroRNA-27a has been shown to stimulate both the wingless-type integration site family, or Wnt signaling, and the bone morphogenetic protein pathways to actively promote bone regeneration, according ...